BREYANZI is a prescription medicine used to treat a type of non-Hodgkin lymphoma:

  • Large B cell lymphoma, when:
    • your first treatment has not worked or your cancer returned within a year of your first treatment, OR...Read more

REMISSION IS POSSIBLE. POWERED BY YOU.

With a one-time* infusion of Breyanzi®, a CAR T cell therapy, you have the chance for complete and lasting remission.

See if Breyanzi may be right for you
  • CAR, chimeric antigen receptor.

  • *The treatment process includes blood collection, CAR T cell creation, administration, and side-effect monitoring.

  • Most people treated with Breyanzi who had no signs of large B cell lymphoma continued to be in complete remission. Because this does not mean the cancer has been cured, regular check-ins with your healthcare team are still needed, and you may have to take medication to manage side effects.

How Breyanzi works

Breyanzi is different from other cancer treatments you may have had before. CAR T cell therapy is made just for you.

LEARN MORE

Breyanzi benefits

See how people in the clinical studies reached complete and lasting remission from large B-cell lymphoma.

See THE OUTCOMES

Real stories

Meet real people and learn about their Breyanzi experiences.

SEE THEIR STORIES

Cell Therapy 360®

Cell Therapy 360 offers solutions-oriented programs for patients and their caregiver throughout the treatment journey.

GET SUPPORT

Treatment center locator

With more certified Breyanzi treatment centers across the US, there may be one closer to home.

Sign up to stay in touch and receive emails with information about Breyanzi

Learn more about Breyanzi with these resources:

Treatment Brochure

Learn more about Breyanzi, a one-time* infusion, including treatment outcomes, how you'll receive it, and what support may be available.

Doctor Discussion Guide

This guide will help you talk to your doctor about Breyanzi and can help answer questions you have about treatment.

  • *The treatment process includes blood collection, CAR T cell creation, administration, and side-effect monitoring.